Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cellulitis | 9 | 2020 | 206 | 2.700 |
Why?
|
| Human papillomavirus 16 | 5 | 2014 | 268 | 0.690 |
Why?
|
| Skin | 6 | 2020 | 4499 | 0.580 |
Why?
|
| Lidocaine | 1 | 2018 | 545 | 0.490 |
Why?
|
| Langerhans Cells | 5 | 2015 | 169 | 0.480 |
Why?
|
| Neutrophils | 4 | 2021 | 3782 | 0.480 |
Why?
|
| Hyperthermia, Induced | 1 | 2018 | 414 | 0.470 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2019 | 789 | 0.420 |
Why?
|
| Staphylococcal Infections | 2 | 2019 | 1396 | 0.420 |
Why?
|
| Anti-Bacterial Agents | 6 | 2020 | 7475 | 0.370 |
Why?
|
| Alphapapillomavirus | 1 | 2013 | 219 | 0.340 |
Why?
|
| Virus Internalization | 2 | 2014 | 504 | 0.340 |
Why?
|
| Papillomavirus Infections | 6 | 2014 | 1639 | 0.330 |
Why?
|
| Receptors, Virus | 1 | 2013 | 652 | 0.330 |
Why?
|
| Home Care Services | 2 | 2020 | 659 | 0.220 |
Why?
|
| Annexin A2 | 2 | 2014 | 43 | 0.210 |
Why?
|
| Diagnostic Errors | 3 | 2019 | 1276 | 0.200 |
Why?
|
| Oncogene Proteins, Viral | 3 | 2014 | 342 | 0.190 |
Why?
|
| Antigens, Neoplasm | 2 | 2008 | 1998 | 0.190 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 15912 | 0.170 |
Why?
|
| Capsid Proteins | 3 | 2014 | 468 | 0.170 |
Why?
|
| Luminescence | 1 | 2020 | 108 | 0.170 |
Why?
|
| Papillomaviridae | 3 | 2015 | 1139 | 0.160 |
Why?
|
| Borrelia burgdorferi | 1 | 2021 | 183 | 0.160 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 5860 | 0.160 |
Why?
|
| Dermatology | 2 | 2019 | 905 | 0.150 |
Why?
|
| Membrane Glycoproteins | 1 | 2008 | 3702 | 0.140 |
Why?
|
| Skin Temperature | 1 | 2017 | 96 | 0.140 |
Why?
|
| Remote Consultation | 1 | 2019 | 241 | 0.140 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 3600 | 0.130 |
Why?
|
| Leukocytosis | 1 | 2017 | 249 | 0.130 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2017 | 231 | 0.120 |
Why?
|
| Lyme Disease | 1 | 2021 | 627 | 0.120 |
Why?
|
| Cyclosporine | 1 | 2017 | 778 | 0.120 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2019 | 426 | 0.120 |
Why?
|
| Churg-Strauss Syndrome | 1 | 2015 | 75 | 0.120 |
Why?
|
| Tachycardia | 1 | 2017 | 598 | 0.120 |
Why?
|
| Foot Diseases | 1 | 2015 | 148 | 0.110 |
Why?
|
| Cost Savings | 1 | 2019 | 903 | 0.110 |
Why?
|
| Bronchiectasis | 1 | 2015 | 141 | 0.110 |
Why?
|
| Cell Cycle | 2 | 2018 | 2925 | 0.110 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2013 | 111 | 0.100 |
Why?
|
| Virion | 1 | 2015 | 428 | 0.100 |
Why?
|
| Interdisciplinary Communication | 1 | 2018 | 932 | 0.100 |
Why?
|
| S100 Proteins | 1 | 2012 | 215 | 0.100 |
Why?
|
| Leg | 1 | 2017 | 1087 | 0.100 |
Why?
|
| Streptococcal Infections | 1 | 2016 | 618 | 0.100 |
Why?
|
| Dermatitis, Atopic | 1 | 2019 | 734 | 0.100 |
Why?
|
| Molecular Biology | 1 | 2015 | 573 | 0.090 |
Why?
|
| Physician's Role | 1 | 2018 | 925 | 0.090 |
Why?
|
| Staphylococcus aureus | 1 | 2019 | 1429 | 0.090 |
Why?
|
| Immunosuppressive Agents | 2 | 2017 | 4215 | 0.090 |
Why?
|
| Emergencies | 1 | 2017 | 1223 | 0.090 |
Why?
|
| Bacteremia | 1 | 2017 | 987 | 0.080 |
Why?
|
| Drug Discovery | 1 | 2018 | 1065 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 2007 | 0.080 |
Why?
|
| Cell Survival | 1 | 2018 | 5749 | 0.080 |
Why?
|
| Humans | 27 | 2021 | 766812 | 0.080 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2009 | 98 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 12985 | 0.080 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2009 | 169 | 0.070 |
Why?
|
| Protein Multimerization | 1 | 2012 | 961 | 0.070 |
Why?
|
| Immune Tolerance | 2 | 2014 | 2328 | 0.070 |
Why?
|
| GPI-Linked Proteins | 1 | 2008 | 472 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2014 | 2931 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 11094 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2018 | 3957 | 0.060 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2009 | 827 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2017 | 3563 | 0.060 |
Why?
|
| Cytokines | 4 | 2015 | 7438 | 0.060 |
Why?
|
| Cell Line | 1 | 2018 | 15564 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 15425 | 0.060 |
Why?
|
| Patient Preference | 2 | 2020 | 946 | 0.050 |
Why?
|
| Immunotherapy | 2 | 2008 | 4747 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2018 | 3459 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 17089 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 14653 | 0.050 |
Why?
|
| Complement C5 | 1 | 2021 | 104 | 0.050 |
Why?
|
| Risk Factors | 2 | 2019 | 74889 | 0.040 |
Why?
|
| Cancer Vaccines | 1 | 2008 | 1042 | 0.040 |
Why?
|
| Age Factors | 1 | 2017 | 18397 | 0.040 |
Why?
|
| Emollients | 1 | 2019 | 41 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 7870 | 0.040 |
Why?
|
| Male | 10 | 2019 | 364154 | 0.040 |
Why?
|
| Skin Diseases, Infectious | 1 | 2019 | 75 | 0.040 |
Why?
|
| Luminescent Measurements | 1 | 2020 | 342 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2009 | 2747 | 0.040 |
Why?
|
| Hospitals, Urban | 1 | 2019 | 494 | 0.030 |
Why?
|
| Hospitals | 2 | 2020 | 3885 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2017 | 42577 | 0.030 |
Why?
|
| Microfluidics | 1 | 2021 | 650 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 26309 | 0.030 |
Why?
|
| Female | 9 | 2019 | 396532 | 0.030 |
Why?
|
| Length of Stay | 2 | 2019 | 6491 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2019 | 1526 | 0.030 |
Why?
|
| Standard of Care | 1 | 2017 | 569 | 0.030 |
Why?
|
| Cell Movement | 2 | 2019 | 5204 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 2018 | 724 | 0.030 |
Why?
|
| Animals | 4 | 2020 | 168939 | 0.030 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2015 | 297 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2019 | 955 | 0.030 |
Why?
|
| HIV Infections | 1 | 2019 | 17532 | 0.030 |
Why?
|
| Aged | 4 | 2019 | 171344 | 0.020 |
Why?
|
| Patient Admission | 1 | 2019 | 1364 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2012 | 424 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 10263 | 0.020 |
Why?
|
| Middle Aged | 4 | 2019 | 223267 | 0.020 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 1217 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2018 | 1512 | 0.020 |
Why?
|
| Exanthema | 1 | 2015 | 502 | 0.020 |
Why?
|
| Swine | 1 | 2020 | 5985 | 0.020 |
Why?
|
| Aminoquinolines | 1 | 2009 | 105 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2012 | 1750 | 0.020 |
Why?
|
| Adult | 3 | 2019 | 223305 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2014 | 1075 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 1604 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6779 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1997 | 1836 | 0.020 |
Why?
|
| Time Factors | 2 | 2019 | 40149 | 0.020 |
Why?
|
| Histones | 1 | 1997 | 2595 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2012 | 3073 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1997 | 2678 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 1997 | 2979 | 0.020 |
Why?
|
| Epitopes | 1 | 2012 | 2526 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 4143 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2015 | 3642 | 0.020 |
Why?
|
| Boston | 1 | 2017 | 9346 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2017 | 3618 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2015 | 8310 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2009 | 996 | 0.010 |
Why?
|
| Quinolines | 1 | 2009 | 769 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 3427 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 2815 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2009 | 1560 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1997 | 7612 | 0.010 |
Why?
|
| Imidazoles | 1 | 2009 | 1168 | 0.010 |
Why?
|
| Logistic Models | 1 | 2017 | 13276 | 0.010 |
Why?
|
| Viral Vaccines | 1 | 2008 | 596 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 2008 | 865 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1997 | 5795 | 0.010 |
Why?
|
| Peptides | 1 | 2014 | 4347 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2009 | 2215 | 0.010 |
Why?
|
| Papillomavirus Vaccines | 1 | 2008 | 497 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2019 | 65286 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 2456 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 13411 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2012 | 3698 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13642 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 2882 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 17609 | 0.010 |
Why?
|
| Genotype | 1 | 2014 | 13036 | 0.010 |
Why?
|
| Neoplasms | 1 | 2008 | 22350 | 0.010 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2008 | 1503 | 0.010 |
Why?
|
| Hemagglutinins | 1 | 1997 | 111 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2009 | 2039 | 0.010 |
Why?
|
| Lung | 1 | 2015 | 10068 | 0.010 |
Why?
|
| RNA, Fungal | 1 | 1997 | 156 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1997 | 816 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 41706 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1997 | 573 | 0.010 |
Why?
|
| Infant | 1 | 2017 | 36459 | 0.010 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 1997 | 496 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2009 | 18986 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1997 | 1525 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 59939 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 8623 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 1997 | 1027 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 20710 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 81657 | 0.010 |
Why?
|
| Child | 1 | 2017 | 80670 | 0.000 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1997 | 3738 | 0.000 |
Why?
|
| Mutation | 1 | 2012 | 30214 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 13644 | 0.000 |
Why?
|
| Promoter Regions, Genetic | 1 | 1997 | 5795 | 0.000 |
Why?
|
| Bacterial Proteins | 1 | 1997 | 3833 | 0.000 |
Why?
|
| Mice | 1 | 2008 | 81898 | 0.000 |
Why?
|
Concepts
(176)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_